Based on the pivotal mechanism of the NIP30/REGγ/TRAF6 axis, we determined that TTP22 can alleviate osteoporosis by promoting the ubiquitin-independent proteasomal degradation of TRAF6 and provide a different strategy for the treatment of osteoporosis. This evidence concerns the gene TRAF6 and osteoporosis.